Volume 97, Issue 8, Pages 983-989 (August 2003) Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma K Spiropoulos, G Trakada, E Nikolaou, E Prodromakis, G Efremidis, A Pouli, A Koniavitou Respiratory Medicine Volume 97, Issue 8, Pages 983-989 (August 2003) DOI: 10.1016/S0954-6111(03)00129-X
Figure 1 FEV1/FVC ratio in asthmatic and COPD “non-desaturators” and “desaturators” patients. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)
Figure 2 SatO2 in asthmatic and COPD “non-desaturators” and “desaturators” patients during daytime. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)
Figure 3 ET-1 in asthmatic and COPD “non-desaturators” and “desaturators” patients and normal controls during daytime. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)
Figure 4 ET-1 in “desaturators” COPD patients during daytime and during sleep. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)
Figure 5 Correlation of SatO2 and ET-1 levels in “desaturators” COPD patients during sleep (P<0.001, r=−0.939). Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)
Figure 6 Correlation of SatO2 and ET-1 levels in “desaturators” COPD patients during daytime (P=0.005, r=−0.632). Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)